Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR<sup>−</sup>/HER2<sup>+</sup>breast cancersRuth Rodríguez‐Barrueco, José M. Silva, Laura Saucedo-Cuevas et al.|Genes & Development|2015Cited by 121
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapyRuth Rodríguez‐Barrueco, José M. Silva|Genes & Development|2017Cited by 90